Can you answer the questions about this case ahead of joining Dr David Chascsa's session.

A 52-year-old man with a history of obesity, hypertension, and type 2 diabetes presents to the clinic for evaluation of elevated liver enzymes. He has a BMI of 34 kg/m² and a family history of liver disease. Recent blood tests reveal elevated ALT, AST, and a high FIB-4 score.

This program is funded by an independent grant from Novo Nordisk. This online education program has been designed solely for healthcare professionals in USA. The content is not available for healthcare professionals in any other region.

Can you answer the questions about this case ahead of joining Prof Sanyal's session by clicking here.

Ms. T, a 45-year-old woman with a BMI of 36 kg/m², has been recently diagnosed with metabolic-associated steatohepatitis (MASH) and type 2 diabetes. Despite taking metformin, she struggles with glycemic control. She's intrigued by the potential of GLP-1 receptor agonists but seeks more information on their effectiveness and how they might fit into her lifestyle.

Ms. T's busy schedule and frequent social engagements often involve dining out, making dietary changes challenging. She's motivated to improve her health but needs a sustainable approach that complements her lifestyle.

This program is funded by an independent grant from Novo Nordisk. This online education program has been designed solely for healthcare professionals in USA. The content is not available for healthcare professionals in any other region.

Question:

A 40-year-old male with MASH is being monitored after initiating a new treatment regimen for his condition. What biomarker would be most useful to evaluate the immediate effectiveness of his treatment?

Answers: >> How did you do?? Answer's here << Or post your answer below!

1 - Hemoglobin A1c

2 - Serum albumin

3 - Gamma-glutamyl transferase (GGT)

4 - C-reactive protein (CRP)

5 - Alpha-fetoprotein (AFP)

Can you answer the questions about this case ahead of joining Prof Sanyal's session?

Mrs. A.B., a 55-year-old woman of South Asian descent, presents for a routine check-up. She denies any current complaints and reports feeling well overall. Her past medical history is significant for well-controlled type 2 diabetes mellitus (T2DM) managed with metformin, and hypertension managed with lisinopril. She leads a sedentary lifestyle and admits to a diet high in processed foods and sugary drinks. Her family history is positive for cardiovascular disease.

On examination, Mrs. A.B. is overweight with a BMI of 28 kg/m². Vital signs are normal. A routine blood panel reveals mildly elevated liver enzymes (ALT and AST) with normal bilirubin levels.

This program is funded by an independent grant from Novo Nordisk. This online education program has been designed solely for healthcare professionals in the USA. The content is not available for healthcare professionals in any other country.